EichorEICHOR
Study identifier: NCT07742696 Synced from ClinicalTrials.gov · August 03, 2026
● Not Yet Recruiting

Comparison of Postoperative Functional Outcomes Between Subvastus and Medial Parapatellar Approach in Total Knee Arthroplasty

Condition: Osteoarthritis (OA) of the Knee  ·  Sponsor: Peking University Third Hospital

PhaseNA
Planned participants84
Who can joinAll sexes, 50 Years to 80 Years
Healthy volunteersNo

About this study

This study aims to compare the effects of the medial parapatellar approach (MP) and the subvastus approach (SV) on postoperative clinical function in total knee arthroplasty (TKA). A total of 84 patients, who visit the Joint Surgery Department of Peking University Third Hospital and are diagnosed with end-stage knee osteoarthritis and require unilateral, primary total knee arthroplasty, will be recruited. The patients will be randomly assigned to two groups, with 42 patients in each group. TKA will be performed using the MP and SV approaches respectively. Postoperative data such as quadriceps muscle strength, the time of first unassisted straight leg raise (SLR), joint range of motion (ROM), KSS score, WOMAC score, SF-12 score, VAS score, and shear wave elastography (SWE) of the medial thigh muscle will be collected. The patients will be followed up for 2 years postoperatively to compare the short-term and long-term clinical functional outcomes of the two surgical approaches.

This description comes directly from the study's public registry record.

Talk to the study team

Ran Zhao, MD  ·  +8613161866294  ·  2411210441@pku.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Orthopaedic Department of Peking University Third HospitalBeijing, Haidian, China

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →